Patents by Inventor Alcino Silva

Alcino Silva has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and treatments for the learning and memory deficits associated with Noonan syndrome
    Patent number: 10835513
    Abstract: Disclosed herein are methods and compositions for treating learning and memory deficits associated with Noonan Syndrome.
    Type: Grant
    Filed: June 27, 2014
    Date of Patent: November 17, 2020
    Assignee: The Regents of the University of California
    Inventors: Alcino Silva, Yong-Seok Lee, Dan Ehninger
  • Methods and Treatments for the Learning and Memory Deficits Associated with Noonan Syndrome
    Publication number: 20160158194
    Abstract: Disclosed herein are methods and compositions for treating learning and memory deficits associated with Noonan Syndrome.
    Type: Application
    Filed: June 27, 2014
    Publication date: June 9, 2016
    Inventors: Alcino Silva, Yong-Seok Lee, Dan Ehninger
  • Treating Learning Deficits with Inhibitors of HMG CoA Reductase
    Publication number: 20120283323
    Abstract: The disclosure provides methods of treating cognitive disorders by administering a HMG CoA reductase inhibitor. Cognitive deficits treatable with the inhibitor compound include those associated with Angelman Syndrome, Neurofibromatosis-1, certain forms of X-linked mental retardation, tuberous sclerosis, Down Syndrome, autism, and attention deficit/hyperactivity disorder.
    Type: Application
    Filed: June 14, 2012
    Publication date: November 8, 2012
    Inventors: Alcino Silva, Yijun Cui, Weidong Li, Steven A. Kushner
  • Treating learning deficits with inhibitors of Hmg CoA reductase
    Patent number: 8222293
    Abstract: The disclosure provides methods of treating cognitive disorders by administering a HMG CoA reductase inhibitor. Cognitive deficits treatable with the inhibitor compound include those associated with Angelman Syndrome, Neurofibromatosis-1, certain forms of X-linked mental retardation, tuberous sclerosis, Down Syndrome, autism, and attention deficit/hyperactivity disorder.
    Type: Grant
    Filed: May 23, 2005
    Date of Patent: July 17, 2012
    Assignee: Regents of the University of Carolina
    Inventors: Alcino Silva, Yijun Cui, Weldong Li, Steven A. Kushner
  • Treating Learning Deficits With Inhibitors of Hmg CoA Reductase
    Publication number: 20070299096
    Abstract: The disclosure provides methods of treating cognitive disorders by administering a HMG CoA reductase inhibitor. Cognitive deficits treatable with the inhibitor compound include those associated with Angelman Syndrome, Neurofibromatosis-1, certain forms of X-linked mental retardation, tuberous sclerosis, Down Syndrome, autism, and attention deficit/hyperactivity disorder.
    Type: Application
    Filed: May 23, 2005
    Publication date: December 27, 2007
    Applicant: REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventor: Alcino Silva